Efficacy and safety of parecoxib versus ketorolac tromethamine for perioperative analgesia:a systematic review / 中国药房
China Pharmacy
; (12): 476-481, 2023.
Article
em Zh
| WPRIM
| ID: wpr-962495
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVE To compare the efficacy and safety of parecoxib and ketorolac tromethamine for perioperative analgesia, and to provide evidence-based reference for clinical drug use. METHODS Retrieved from PubMed, Embase, the Cochrane Library, CNKI, VIP, Wanfang Data, Baidu and Google, randomized controlled trials (RCT) about parecoxib (trial group) versus ketorolac tromethamine (control group) for perioperative analgesia were collected from the inception to Jun. 17th, 2022. After screening the literature and extracting the data, the quality of the included literature was evaluated using the bias risk assessment tool recommended by Cochrane system evaluator manual 5.1.0. Meta-analysis, sensitivity analysis and publication bias analysis were performed with RevMan 5.4 software. RESULTS A total of 12 RCTs were included, with 1 118 patients. Meta- analysis results showed that at the time of administration before anesthesia induction, there was no statistically significant difference between the 2 groups in visual analogue scale (VAS) [MD=-0.16, 95%CI (-0.41, 0.09), P=0.20], numerical rating scale (NRS) [MD=0.01, 95%CI (-0.36, 0.38), P=0.97], postoperative bleeding [MD=0.15, 95%CI (-0.63, 0.93), P=0.71], and consumption of opioid analgesics [MD=0.12, 95%CI (-0.77, 1.01), P=0.79]. At the time of postoperative administration, VAS and bleeding volume at 48 h after operation of trial group were significantly lower than control group (P<0.05). The results of subgroup analysis by different com assessment time points showed that the VAS of patients in trial group at 0 h after operation were significantly lower than control group at the time of administration before anesthesia induction; at the time of postoperative administration, VAS of patients in the trial group at 12 h and 48 h after operation were significantly lower than control group (P<0.05). There was no statistical significance in the incidence of ADR between 2 groups [RR=0.93,95%CI (0.78,1.11),P=0.43]. The results of subgroup analysis according to different types of adverse reactions showed that the incidence of nausea and vomiting of trial group was significantly lower than control group, and the incidence of other adverse reactions was significantly higher than control group (P<0.05). Results of sensitivity analysis showed that study results were stable and reliable. Results of publication bias analysis showed that there was great possibility of publication bias in this study. CONCLUSIONS The efficacy of parecoxib is equivalent to that of ketorolac tromethamine for perioperative analgesia before operation; at the time of administration after operation, parecoxib has better analgesic effect and less postoperative bleeding; the incidence of nausea and vomiting caused by parecoxib is lower at any time of administration.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Systematic_reviews
Idioma:
Zh
Revista:
China Pharmacy
Ano de publicação:
2023
Tipo de documento:
Article